Fingerprint
Dive into the research topics of 'A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically